This all confirms that Biota and GSK have let shareholders down . The good news is that BTA will increase no matter the incompetence of its Management. Thanks god for Boffins.
"George Abercrombie, President and Chief Executive Officer of Hoffmann-La Roche Inc. (ROG.VX: Quote, Profile, Research), said the U.S. Health and Human Services Department had tripled its order for Tamiflu, an antiviral that helps treat both seasonal flu and H5N1.
He said Roche had a letter of intent to buy 46 million treatment courses of the pills, licensed from California-based Gilead Sciences Inc. (GILD.O: Quote, Profile, Research)"
